Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 18

    1.

    HPV vaccine in Rwanda: different disease, same double standard.

    Binagwaho A, Wagner CM, Nutt CT.

    Lancet. 2011 Dec 3;378(9807):1916. No abstract available.

    PMID:
    22137840
    [PubMed - indexed for MEDLINE]
    2.

    Ethical behaviour in clinical research--a lesson from the past.

    The Lancet.

    Lancet. 2011 Sep 10;378(9795):962. No abstract available.

    PMID:
    21907844
    [PubMed - indexed for MEDLINE]
    3.

    Trials of antenatal syphilis screening urgently needed.

    Low N, Hawkes SJ.

    Lancet. 2011 Sep 3;378(9794):877; author reply 877-8. No abstract available.

    PMID:
    21890048
    [PubMed - indexed for MEDLINE]
    4.

    Syphilis on the rise in the USA.

    [No authors listed]

    Lancet. 2011 Aug 13;378(9791):542. No abstract available.

    PMID:
    21840445
    [PubMed - indexed for MEDLINE]
    5.

    Male circumcision for prevention of oncogenic HPV infection.

    Tobian AA, Quinn TC, Gray RH.

    Lancet. 2011 Jul 23;378(9788):314-5; author reply 315. No abstract available.

    PMID:
    21784258
    [PubMed - indexed for MEDLINE]
    6.

    Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study.

    Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM.

    Lancet. 2011 Jun 18;377(9783):2085-92.

    PMID:
    21684381
    [PubMed - indexed for MEDLINE]
    7.

    HPV vaccine effect: is the glass half full or half empty?

    Saraiya M, Hariri S.

    Lancet. 2011 Jun 18;377(9783):2057-8. No abstract available. Erratum in: Lancet. 2011 Aug 27;378(9793):770.

    PMID:
    21684367
    [PubMed - indexed for MEDLINE]
    8.

    Listening to narratives from the Tuskegee syphilis study.

    Reverby SM.

    Lancet. 2011 May 14;377(9778):1646-7. No abstract available.

    PMID:
    21591285
    [PubMed - indexed for MEDLINE]
    9.

    Financing HPV vaccination in developing countries.

    [No authors listed]

    Lancet. 2011 May 7;377(9777):1544. No abstract available.

    PMID:
    21550467
    [PubMed - indexed for MEDLINE]
    10.

    Genital infection with HPV in men: research into practice.

    Monsonego J.

    Lancet. 2011 Mar 12;377(9769):881-3. Epub 2011 Feb 28. No abstract available.

    PMID:
    21367447
    [PubMed - indexed for MEDLINE]
    11.

    Male circumcision and HPV transmission to female partners.

    Giuliano AR, Nyitray AG, Albero G.

    Lancet. 2011 Jan 15;377(9761):183-4. Epub 2011 Jan 6. No abstract available.

    PMID:
    21216001
    [PubMed - indexed for MEDLINE]
    12.

    HPV vaccine suspension in India.

    Feinberg M.

    Lancet. 2010 Nov 13;376(9753):1644-5. No abstract available.

    PMID:
    21075255
    [PubMed - indexed for MEDLINE]
    13.

    The India HPV-vaccine suspension.

    Larson HJ, Brocard P, Garnett G.

    Lancet. 2010 Aug 21;376(9741):572-3. No abstract available.

    PMID:
    20728739
    [PubMed - indexed for MEDLINE]
    14.

    Treatment of HIV infection with drugs for HSV-2 infection.

    Huttner A, Calmy A.

    Lancet. 2010 Jul 10;376(9735):88; author reply 88. No abstract available.

    PMID:
    20621229
    [PubMed - indexed for MEDLINE]
    15.

    HPV prevention: waiting for screening services.

    Finn A.

    Lancet. 2010 May 15;375(9727):1694. No abstract available.

    PMID:
    20472170
    [PubMed - indexed for MEDLINE]
    16.

    HPV vaccination: waiting for evidence of effectiveness.

    Suba EJ, Raab SS; Viet/American Cervical Cancer Prevention Project.

    Lancet. 2010 Feb 20;375(9715):639-40. No abstract available.

    PMID:
    20171401
    [PubMed - indexed for MEDLINE]
    17.

    Treating HIV infection with drugs for HSV-2 infection?

    Buvé A, Lynen L.

    Lancet. 2010 Mar 6;375(9717):782-4. Epub 2010 Feb 12. No abstract available.

    PMID:
    20153889
    [PubMed - indexed for MEDLINE]
    18.

    Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

    Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Magaret AS, Wang RS, Kidoguchi L, Barnes L, Ridzon R, Corey L, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.

    Lancet. 2010 Mar 6;375(9717):824-33. Epub 2010 Feb 12.

    PMID:
    20153888
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk